Roger Kei Aoki is a prominent inventor based in Coto de Caza, California. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins and neurotoxin formulations. With a total of 6 patents to his name, Aoki's work has the potential to impact pain management and therapeutic applications.

Latest Patents

Aoki's latest patents include groundbreaking innovations such as fusion proteins that comprise a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds to a galanin receptor. These proteins are designed for methods of treating, preventing, or ameliorating pain. Another notable patent involves a single-chain polypeptide fusion protein that integrates a non-cytotoxic protease capable of cleaving proteins in the exocytic fusion apparatus of nociceptive sensory afferents. Additionally, he has developed a neurotoxin formulated with a hyaluronic acid carrier, which enhances the residency time of the toxin at a subdermal location while minimizing complications and side effects.

Career Highlights

Throughout his career, Aoki has worked with leading companies in the biotechnology sector, including Allergan, Inc. and Ipsen Bioinnovation Limited. His experience in these organizations has allowed him to refine his expertise and contribute to innovative solutions in pain management and therapeutic interventions.

Collaborations

Aoki has collaborated with notable professionals in his field, including Minglei Cui and Stephen W. Jenkins. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in biotechnology.

Conclusion

Roger Kei Aoki's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative solutions in pain management and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.